Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review

Medard Kofi Adu, Reham Shalaby, Pierre Chue, Vincent I.O. Agyapong

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

19 Citas (Scopus)

Resumen

Treatment‐resistant depression (TRD) is associated with significant disability, and due to its high prevalence, it results in a substantive socio‐economic burden at a global level. TRD is the inability to accomplish and/or achieve remission after an adequate trial of antidepressant treat-ments. Studies comparing repetitive transcranial magnetic stimulation (rTMS) with electroconvul-sive therapy (ECT) and pharmacotherapy have revealed evidence of the therapeutic efficacy of rTMS in TRD. These findings suggest a crucial role for rTMS in the management of TRD. This article aims to conduct a comprehensive scoping review of the current literature concerning the use of rTMS and its therapeutic efficacy as a treatment modality for TRD. PubMed, PsycINFO, Medline, Embase, and Cinahl were used to identify important articles on rTMS for TRD. The search strategy was limited to English articles within the last five years of data publication. Articles were included if they reported on a completed randomized controlled trial (RCT) of rTMS intervention for TRD. The exclusion criteria involved studies with rTMS for the treatment of conditions other than TRD, and study and experimental protocols of rTMS on TRD. In total, 17 studies were eligible for inclu-sion in this review. The search strategy spanned studies published in the last five years, to the date of the data search (14 February 2022). The regional breakdown of the extracted studies was North American (n = 9), European (n = 5), Asian (n = 2) and Australian (n = 1). The applied frequencies of rTMS ranged from 5 Hz to 50 Hz, with stimulation intensities ranging from 80% MT to 120% MT. Overall, 16 out of the 17 studies suggested that rTMS treatment was effective, safe and tolerated in TRD. For patients with TRD, rTMS appears to provide significant benefits through the reduction of depressive symptoms, and while there is progressive evidence in support of the same, more research is needed in order to define standardized protocols of rTMS application in terms of localiza-tion, frequency, intensity, and pulse parameters.

Idioma originalEnglish
Número de artículo195
PublicaciónBehavioral Sciences
Volumen12
N.º6
DOI
EstadoPublished - jun. 2022

Nota bibliográfica

Funding Information:
Funding: This study was supported by grants from the Mental Health Foundation and the Douglas Harden Trust Fund.

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

ASJC Scopus Subject Areas

  • Ecology, Evolution, Behavior and Systematics
  • Development
  • Genetics
  • General Psychology
  • Behavioral Neuroscience

PubMed: MeSH publication types

  • Journal Article
  • Review

Huella

Profundice en los temas de investigación de 'Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review'. En conjunto forman una huella única.

Citar esto